ACDF Brief comments: What has changed significantly in evaluating and considering CV risk in managing patients with diabetes?1

3' education - Apr. 3, 2019 - Hanoi, Vietnam - Prof. John E Deanfield - Asian Cardio Diabetes Forum 2019

Expert faculty provide brief commentaries on content related to the Asian Cardio Diabetes Forum 2019. Prof. John E Deanfield comments on what he thinks has changed significantly in evaluating and considering CV risk in managing patients with diabetes?

Faculty

John E Deanfield, MD, London, United Kingdom. Prof Deanfield is Professor of Cardiology at University College London (UCL) and Consultant Cardiologist at the Barts Heart Centre (BHC) London UK. He is the Director of the National Centre for Cardiovascular disease Prevention and Outcomes (NCCPO) at UCL, and Chairman of National Institute for Cardiovascular (CV) Outcomes Research (NICOR) which incorporates the national databases for cardiovascular outcomes

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

The Asian Cardio Diabetes Forum was funded by Boehringer Ingelheim Singapore

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.